CN Patent

CN117897160A — 特发性震颤的治疗

Assigned to Sage Therapeutics Inc · Expires 2024-04-16 · 2y expired

What this patent protects

本发明提供一种治疗有需要的受试者的特发性震颤的方法，所述方法包括施用化合物1 或其药学上可接受的盐，或包含化合物1或其药学上可接受的盐的药物组合物，其中所述受试者(a)在治疗开始之后经历至少约5％的震颤幅度减小，(b)在治疗开始之后经历TETRAS日常生活活动(ADE)子量表总评分降低，或(c)两者兼有。

USPTO Abstract

本发明提供一种治疗有需要的受试者的特发性震颤的方法，所述方法包括施用化合物1 或其药学上可接受的盐，或包含化合物1或其药学上可接受的盐的药物组合物，其中所述受试者(a)在治疗开始之后经历至少约5％的震颤幅度减小，(b)在治疗开始之后经历TETRAS日常生活活动(ADE)子量表总评分降低，或(c)两者兼有。

Drugs covered by this patent

Patent Metadata

Patent number
CN117897160A
Jurisdiction
CN
Classification
—
Expires
2024-04-16
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.